Iris Reyhan
YOU?
Author Swipe
View article: Impact of Concomitant Methotrexate Use and Prior Biologic Disease‐Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial
Impact of Concomitant Methotrexate Use and Prior Biologic Disease‐Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial Open
Objective We evaluate tofacitinib efficacy and safety in patients with juvenile idiopathic arthritis (JIA) stratified by concomitant methotrexate and prior biologic disease‐modifying antirheumatic drug (bDMARD) treatment. Methods In this t…
View article: Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis
Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis Open
Background Prompt diagnosis of juvenile idiopathic arthritis (JIA) is important to avoid long term complications. Elevated serum 14–3-3η levels improve the diagnostic sensitivity of rheumatoid factor (RF) and cyclic citrullinated peptide (…
View article: Prevalence and Significance of Serum 14-3-3η in Juvenile Idiopathic Arthritis
Prevalence and Significance of Serum 14-3-3η in Juvenile Idiopathic Arthritis Open
Background: Prompt diagnosis of juvenile idiopathic arthritis (JIA) is important to avoid long term complications. Elevated serum 14-3-3η levels improve the diagnostic sensitivity of rheumatoid factor (RF) and cyclic citrullinated peptide …
View article: Prevalence and Significance of Serum 14-3-3η(eta) in Juvenile Idiopathic Arthritis
Prevalence and Significance of Serum 14-3-3η(eta) in Juvenile Idiopathic Arthritis Open
Background Prompt diagnosis of juvenile idiopathic arthritis (JIA) is important to avoid long term complications. Elevated serum 14-3-3η levels improve the diagnostic sensitivity of rheumatoid factor (RF) and cyclic citrullinated peptide (…